ClearBridge Focus Value ESG ETF (BATS: CFCV)

Latest News for ClearBridge Focus Value ESG ETF (BATS:CFCV)

Tel,Aviv,,Israel,-,March,30,,2016:,Intel,Logo,On

Entertainment

Equities

News

Sports

Markets

Tech

General

CFCV

FTXL

INTC

Intel unveils plans to provide AI services at the Olympic and Paralympic Games, focusing on 8K live streaming and accessibility innovations.

Intel To Provide AI Services At Olympic And Paralympic Games - Eyes On 8K Live Streaming, Accessibility For Visually Impaired &amp; More

Movers

CIBR

DGIN

INFY

Intel Corporation stock declines premarket as it broadens collaboration with Infosys Limited to bolster AI solutions for enterprises, aiming for cost efficiency and responsible AI adoption.

What&#39;s Going On With Intel Stock Wednesday?

ClearBridge Focus Value ESG ETF

Biotech

Novo Nordisk CEO On Compounded Versions Of Co's Drug Semaglutide In The U.S. Says "We Can Not Vouch For The Quality Of Those Medicines"; Co Is Conducting A Large Phase 3 Program Exploring The Benefit Of Using Semaglutide In Alzheimer's Disease; Expects Clinical Data Next Year From Phase 3 Program Of Semaglutide In Alzheimer's Disease

WIIM

Lowe's shares are trading lower after the company reported Q1 financial results. The stock initially traded higher, but it has since reversed.

Global

Novo Nordisk CEO, On Lilly's Diabetes Drug Approval In China, Says "It's One More Market Where There Will Be Two Critical Contenders Competing"; "Supplying All We Can", There Is No Drug Shortage Of Our Type 2 Diabetes Drug Ozempic In The U.S. Market; On Compounded Versions Of Co's Drug Semaglutide In The U.S. Says "Focused On Securing Patients Have Access To High Quality Products"

AAPL

CMCSA

NFLX

Comcast Introduces Peacock, Netflix, And Apple TV+ Streaming Bundle; Xfinity Internet And TV Customers Nationwide Can Add New Xfinity Streamsaver Bundle For $15/month; Combined Streamsaver And Now TV For $30/month; Combine Streamsaver With Now TV To Get These 3 Streaming Apps, Plus 40+ Popular Streaming Channels For $30/month

AutoZone shares are trading lower after the company reported worse-than-expected Q3 sales results.

Stock Split

JP Morgan CEO Jamie Dimon Says Not Expecting A Stock Split In The Foreseeable Future

Trading Ideas

MGRX

Mangoceuticals Shares Resume Trade

Macro Economic Events

Economics

U.S. Treasury's Yellen Says There Does Not Need To Be Detailed Coordination Between G7 Countries On China Trade Actions, But More Forceful To Speak With China As A Group On Overcapacity; Bankers In Frankfurt Meetings Expressed Very Strong Commitment To Enforcing Russian Sanctions, Stopping Flow Of Military Materials To Russia

U.S. Treasury's Yellen Says Concerns About China Strategy Are Shared Among G7 Finance Ministers; If We Were To Use Secondary Russian Sanctions On Banks, We Would Do So In A Judicious Manner; Not Every Detail Needs To Be Worked Out On Russian Asset Plan By Time Of G7 Leaders Summit In Puglia

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>Snowflake</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with SNOW, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 9 uncommon options trades for Snowflake.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 22% bullish and 55%, bearish.</p>
<p>Out of all of the special options we uncovered, 4 are puts, for a total amount of $169,750, and 5 are calls, for a total amount of $1,390,930.</p>
<h3>Projected Price Targets</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $90.0 and $200.0 for Snowflake, spanning the last three months.</p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Snowflake's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Snowflake's substantial trades, within a strike price spectrum from $90.0 to $200.0 over the preceding 30 days.</p>
<h3>Snowflake Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1716302787_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/21/24</td>
<td>$11.05</td>
<td>$10.9</td>
<td>$10.91</td>
<td>$165.00</td>
<td>$1.0M</td>
<td>3.6K</td>
<td>1.0K</td>
</tr>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>05/24/24</td>
<td>$5.45</td>
<td>$5.4</td>
<td>$5.4</td>
<td>$170.00</td>
<td>$116.6K</td>
<td>4.1K</td>
<td>256</td>
</tr>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/21/24</td>
<td>$2.39</td>
<td>$2.24</td>
<td>$2.24</td>
<td>$200.00</td>
<td>$89.6K</td>
<td>6.8K</td>
<td>428</td>
</tr>
<tr>
<td>SNOW</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$6.35</td>
<td>$6.15</td>
<td>$6.29</td>
<td>$120.00</td>
<td>$62.9K</td>
<td>1.6K</td>
<td>100</td>
</tr>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/21/24</td>
<td>$5.5</td>
<td>$5.25</td>
<td>$5.46</td>
<td>$180.00</td>
<td>$54.6K</td>
<td>4.2K</td>
<td>110</td>
</tr>
</tbody>
</table>
</p>
<h3>About Snowflake</h3>
<p>Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that came public in 2020. To date, the company has over 3,000 customers, including nearly 30% of the Fortune 500 as its customers. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to easily buy and ingest data almost instantaneously compared with a traditionally months-long process. Overall, the company is known for the fact that all of its data solutions that can be hosted on various public clouds.</p>
<h3>Present Market Standing of Snowflake</h3>
<ul>
<li>Currently trading with a volume of 796,576, the SNOW's price is down by -0.59%, now at $163.8. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 1 days.</li>
</ul>
<h3>What The Experts Say On Snowflake</h3>
<p>A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $218.33333333333334.</p>
<ul>
<li>Maintaining their stance, an analyst from RBC Capital continues to hold a Outperform rating for Snowflake, targeting a price of $220. </li>
<li>An analyst from JMP Securities downgraded its action to Market Outperform with a price target of $235. </li>
<li>An analyst from B of A Securities persists with their Neutral rating on Snowflake, maintaining a target price of $200. </li>
</ul>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Snowflake, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

SNOW

Snowflake Unusual Options Activity

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>Shopify</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with SHOP, it often means somebody knows something is about to happen.</p>
<p>Today, Benzinga's options scanner spotted 13 options trades for <strong>Shopify</strong>.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 53% bullish and 23%, bearish.</p>
<p>Out of all of the options we uncovered, there was 1 put, for a total amount of $39,744, and 12, calls, for a total amount of $1,228,008.</p>
<h3>Predicted Price Range</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $25.0 and $95.0 for Shopify, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Shopify's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Shopify's substantial trades, within a strike price spectrum from $25.0 to $95.0 over the preceding 30 days.</p>
<h3>Shopify Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1716302782_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>SHOP</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$28.9</td>
<td>$27.0</td>
<td>$28.9</td>
<td>$30.00</td>
<td>$546.2K</td>
<td>202</td>
<td style="text-align: right;">200</td>
</tr>
<tr>
<td>SHOP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$37.05</td>
<td>$36.25</td>
<td>$36.25</td>
<td>$25.00</td>
<td>$278.8K</td>
<td>230</td>
<td style="text-align: right;">77</td>
</tr>
<tr>
<td>SHOP</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$16.55</td>
<td>$15.5</td>
<td>$15.5</td>
<td>$60.00</td>
<td>$77.5K</td>
<td>1.8K</td>
<td style="text-align: right;">85</td>
</tr>
<tr>
<td>SHOP</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$16.8</td>
<td>$15.5</td>
<td>$15.85</td>
<td>$60.00</td>
<td>$55.4K</td>
<td>1.8K</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>SHOP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$6.3</td>
<td>$6.15</td>
<td>$6.15</td>
<td>$95.00</td>
<td>$50.4K</td>
<td>7.4K</td>
<td style="text-align: right;">99</td>
</tr>
</tbody>
</table>
</p>
<h3>About Shopify</h3>
<p>Shopify offers an e-commerce platform primarily to small and medium-size businesses. The firm has two segments. The subscription solutions segment allows Shopify merchants to conduct e-commerce on a variety of platforms, including the company's website, physical stores, pop-up stores, kiosks, social networks (Facebook), and Amazon. The merchant solutions segment offers add-on products for the platform that facilitate e-commerce and include Shopify Payments, Shopify Shipping, and Shopify Capital.</p>
<p>Following our analysis of the options activities associated with Shopify, we pivot to a closer look at the company's own performance.</p>
<h3>Where Is Shopify Standing Right Now?</h3>
<ul>
<li>With a volume of 2,149,664, the price of SHOP is down -1.66% at $57.93. </li>
<li>RSI indicators hint that the underlying stock may be oversold.</li>
<li>Next earnings are expected to be released in 71 days.</li>
</ul>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Shopify, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


SHOP

Looking At Shopify's Recent Unusual Options Activity

<p>Financial giants have made a conspicuous bearish move on CVS Health. Our analysis of options history for CVS Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) revealed 8 unusual trades.</p>
<p>Delving into the details, we found 37% of traders were bullish, while 62% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $96,030, and 5 were calls, valued at $254,769.</p>
<h3>What's The Price Target?</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $50.0 to $65.0 for CVS Health over the recent three months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for CVS Health's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of CVS Health's whale trades within a strike price range from $50.0 to $65.0 in the last 30 days. </p>
<h3>CVS Health Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1716302777_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CVS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/24/24</td>
<td>$0.54</td>
<td>$0.49</td>
<td>$0.49</td>
<td>$57.00</td>
<td>$73.5K</td>
<td>4.9K</td>
<td>3.1K</td>
</tr>
<tr>
<td>CVS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/24/24</td>
<td>$0.5</td>
<td>$0.49</td>
<td>$0.5</td>
<td>$57.00</td>
<td>$68.7K</td>
<td>4.9K</td>
<td>1.4K</td>
</tr>
<tr>
<td>CVS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/16/24</td>
<td>$0.76</td>
<td>$0.71</td>
<td>$0.71</td>
<td>$65.00</td>
<td>$42.6K</td>
<td>1.5K</td>
<td>607</td>
</tr>
<tr>
<td>CVS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/20/24</td>
<td>$6.75</td>
<td>$6.65</td>
<td>$6.75</td>
<td>$62.50</td>
<td>$40.5K</td>
<td>1.3K</td>
<td>63</td>
</tr>
<tr>
<td>CVS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$8.2</td>
<td>$7.05</td>
<td>$8.1</td>
<td>$50.00</td>
<td>$40.5K</td>
<td>926</td>
<td>50</td>
</tr>
</tbody>
</table>
</p>
<h3>About CVS Health</h3>
<p>CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the us. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 26 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all its existing business lines.</p>
<p>Following our analysis of the options activities associated with CVS Health, we pivot to a closer look at the company's own performance.</p>
<h3>CVS Health's Current Market Status</h3>
<ul>
<li>With a volume of 3,765,582, the price of CVS is down -0.73% at $56.98. </li>
<li>RSI indicators hint that the underlying stock may be oversold.</li>
<li>Next earnings are expected to be released in 71 days.</li>
</ul>
<h3>Professional Analyst Ratings for CVS Health</h3>
<p>Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $62.8.</p>
<ul>
<li>An analyst from B of A Securities persists with their Buy rating on CVS Health, maintaining a target price of $77. </li>
<li>Maintaining their stance, an analyst from Wells Fargo continues to hold a Equal-Weight rating for CVS Health, targeting a price of $60. </li>
<li>An analyst from TD Cowen downgraded its action to Hold with a price target of $59. </li>
<li>An analyst from Cantor Fitzgerald downgraded its action to Neutral with a price target of $58. </li>
<li>Reflecting concerns, an analyst from UBS lowers its rating to Neutral with a new price target of $60.</li>
</ul>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for CVS Health with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Market Whales and Their Recent Bets on CVS Options

<p>RBC Capital  analyst Ashish Sabadra   reiterates Ecolab (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ECL#NYSE">ECL</a>) with a Outperform and maintains $260 price target.</p>


Price Target

Reiteration

Analyst Ratings

RBC Capital Reiterates Outperform on Ecolab, Maintains $260 Price Target

<p><strong>Ford Motor Co.</strong>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) has reportedly&nbsp;provided its support for&nbsp;the Biden administration&#8217;s initiative&nbsp;to significantly reduce vehicle emissions by 2032.</p>
<p>This stance directly opposes Republican claims that the new environmental regulations are detrimental to business, reported Reuters.</p>
<p>Ford, the second-largest automaker in the U.S., endorsed the Environmental Protection Agency&#8217;s (EPA) March announcement, which&nbsp;<a target="_blank" href="https://www.epa.gov/newsreleases/biden-harris-administration-finalizes-strongest-ever-pollution-standards-cars-position" rel="noreferrer noopener">aims&nbsp;</a>to decrease passenger vehicle emissions by nearly 50% by 2032 from 2027 levels.&nbsp;</p>
<p>The Dearborn-based company emphasized its commitment to long-term planning to comply with these stringent standards.&nbsp;</p>
<p>Former President Donald Trump,&nbsp;who is&nbsp;vying for a return to the White House, has pledged to overturn the Biden administration&#8217;s regulations.&nbsp;</p>
<p>Meanwhile, a coalition of major automakers, including&nbsp;<strong>General Motors</strong>&nbsp;<strong>Co&nbsp;</strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>),&nbsp;<strong>Toyota Motor</strong>&nbsp;<strong>Corp&nbsp;</strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TM#NYSE">TM</a>), and&nbsp;<strong>Volkswagen</strong>&nbsp;<strong>AG&nbsp;</strong>(OTC:<a class="ticker" href="https://www.benzinga.com/stock/VWAGY#OTC">VWAGY</a>), has shown support for specific aspects of the rule.&nbsp;</p>
<p><strong><em>Also&nbsp;Read</em></strong><em>:&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/equities/24/05/38763987/ford-motor-hires-lucid-groups-ex-cfo-sherry-house-jim-farley-bids-we-urgently-build-a-profitable" rel="noreferrer noopener">Ford Motor Hires Lucid Group&#8217;s Ex-CFO Sherry House &#8211; Jim Farley Bids, &#8216;We Urgently Build A Profitable EV Business!&#8217;</a></em></p>
<p>The Alliance for Automotive Innovation, representing these companies, supported the inclusion of EVs in emissions averaging and the exclusion of upstream emissions from compliance metrics.</p>
<p>In contrast, 25 Republican-led states have initiated legal action against the EPA, arguing that the new regulations are both illegal and impractical, the report added.&nbsp;</p>
<p>This lawsuit reflects a broader contention that the Biden administration aims to transform the American vehicle market through stringent emissions rules, effectively compelling automakers to pivot towards EV production.</p>
<p>Conversely, 22 states, led by California, backed the EPA&#8217;s emissions standards, citing potential harm if future reductions in vehicle emissions&nbsp;are not mandated, per the report.&nbsp;</p>
<p>These regulations represent President Joe Biden&#8217;s effort to address climate change, a core component of his policy agenda.&nbsp;</p>
<p>The EPA projects that 35% to 56% of new vehicles sold from 2030 to 2032 will be electric, reflecting the administration&#8217;s climate goals.</p>
<p><strong>Price Action</strong>: F shares are trading lower by 0.62% at $12.08 at&nbsp;the last check Tuesday.</p>
<p><strong><em>Disclaimer</em></strong>:&nbsp;<em>This content was partially produced&nbsp;with the help of&nbsp;AI tools and&nbsp;was&nbsp;reviewed and published by Benzinga editors.</em></p>
<p><strong><em>Read Next</em></strong><em>: <a href="https://www.benzinga.com/news/24/05/38759934/ford-to-increase-production-at-valencia-plant-with-new-model" target="_blank" rel="noreferrer noopener">Ford To Increase Production At Valencia Plant With New Model</a></em></p>
<p><em>Photo by Shuttershock</em></p>


Media

VWAGY

Ford Endorses Biden's Emission Rules Even As Republicans Oppose: Report

<p><strong>Biodexa Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDRX#NASDAQ">BDRX</a>) </strong>stock is trading higher. The company on Tuesday announced progress towards the treatment of <a href="https://www.benzinga.com/general/biotech/24/05/38939273/biodexa-pharmaceuticals-presents-phase-2-clinical-trial-results-of-its-newly-licensed-erapa-in-fa">Familial Adenomatous Polyposis.</a></p>
<p><strong>What Happened:</strong> Biodexa, a clinical-stage biopharmaceutical company dedicated to acquiring and developing innovative solutions for diseases with unmet medical needs, has announced positive statistically significant findings from the Phase 2 clinical trial of eRapa in Familial Adenomatous Polyposis.</p>
<p>During the trial, patients were divided into three groups of 10, receiving different doses of the treatment over 12 months. Endoscopic exams were conducted at the start and after six months to evaluate safety, tolerability and changes in polyp size.</p>
<p>The results of the experiment showed eRapa, an oral tablet formulation of rapamycin, appeared safe and well-tolerated with a significant 24% reduction in the total polyp burden at six months compared with baseline, as well as an overall 83% non-progression rate.</p>
<p>The results of the Phase 2 trial based on six month data are scheduled for presentation at the 2024 Digestive Disease Week annual meeting in Washington D.C.</p>
<p><em>Related Link: <a href="https://www.benzinga.com/general/biotech/24/05/38941485/eli-lilly-secures-china-nod-for-popular-weight-lossdiabetes-drug-tirzepatide">Eli Lilly Secures China Nod For Popular Weight Loss/Diabetes Drug Tirzepatide</a></em></p>
<h2 class="wp-block-heading">How To Buy BDRX Stock</h2>
<p>By now you're likely curious about how to participate in the market for Biodexa Pharmaceuticals &#8211; be it to purchase shares, or even attempt to bet against the company.</p>
<p>Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share. In the case of Biodexa Pharmaceuticals, which is trading at $2.28 as of publishing time, $100 would buy you 43.86 shares of stock.</p>
<p>If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.</p>
<p><strong>BDRX Price Action:</strong> At the time of writing, Biodexa Pharmaceuticals shares were up 78.4% at $2.20, according to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>
<p><em>Image: 911619 from Pixabay</em>.</p>


BDRX

What's Going On With Biodexa Pharmaceuticals Stock?

Mangoceuticals Shares Halted On Circuit Breaker To The Upside, Stock Now Up 342.7%

MGOL

MGO Global Shares Resume Trade Then Halted On Circuit Breaker To The Downside, Stock Now Up 465.5%

<p>RBC Capital  analyst Sabahat Khan   maintains ATS (TSX:<a class="ticker" href="https://www.benzinga.com/stock/ATS#TSX">ATS</a>) with a Outperform and lowers the price target from C$65 to C$60.</p>


TSX:ATS

RBC Capital Maintains Outperform on ATS, Lowers Price Target to C$60

Management

Pixar Animation To Lay Off ~14% Of Workforce

<p>RBC Capital  analyst Paul Treiber   reiterates Altus Group (TSX:<a class="ticker" href="https://www.benzinga.com/stock/AIF#TSX">AIF</a>) with a Sector Perform and maintains C$52 price target.</p>


TSX:AIF

RBC Capital Reiterates Sector Perform on Altus Group, Maintains C$52 Price Target

ClearBridge Global Infrastructure Income Strategy Q1 2024 Portfolio Manager Commentary

ClearBridge Global Growth Strategy Q1 2024 Portfolio Manager Commentary

ClearBridge All Cap Growth Strategy Q1 2024 Commentary

ClearBridge Energy MLP Strategy Q1 2024 Portfolio Manager Commentary

ClearBridge Canadian Dividend Plus Strategy Q1 2024 Commentary

ClearBridge All Cap Value Strategy Q1 2024 Portfolio Manager Commentary

ClearBridge Global Infrastructure Value Strategy Q1 2024 Commentary

ClearBridge Small Cap Value Strategy Q1 2024 Portfolio Manager Commentary

ClearBridge SMID Cap Growth Strategy Q1 2024 Commentary

ClearBridge Global Value Improvers Strategy Q1 2024 Commentary

ABNB

ADBE

ALTMW

AMZN

APAJF

ARIS

ASML

AVGO

BIIB

CACG

CMSQF

CMSQY

CRWD

CSCO

DAIUF

DFKCY

DSKYF

DSNKY

EDNMF

EDNMY

EDPFY

ELCPF

ENLAY

ENLC

EQBBF

ESOCF

FERVF

GBNXF

GOOGL

GWRE

INFR

KNTK

LRGE

MLTX

MNDY

MPLX

MPLXP

MSFT

NVDA

ODFL

PAAPU

PEGRF

PEGRY

PGPEF

PODD

PUBGY

PYPL

TRAUF

TRGP

TSYHF

TSYHY

WDAY

WOLF

XROLF

YLDE

ZLAB

ZLDPF

Intel To Provide AI Services At Olympic And Paralympic Games - Eyes On 8K Live Streaming, Accessibility For Visually Impaired & More

What's Going On With Intel Stock Wednesday?

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for ClearBridge Focus Value ESG ETF (BATS:CFCV)

Wednesday, April 17, 2024

Wednesday, April 10, 2024